RIM
ABBV icon

Rakuten Investment Management’s AbbVie ABBV Stock Holding History

Rakuten Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.9M Buy
262,298
+29,834
+13% +$6.62M 0.11% 33
2025
Q4 		$53.7M Buy
232,464
+23,954
+11% +$5.46M 0.18% 32
2025
Q3 		$46.5M Buy
+208,510
New +$42.5M 0.17% 31
2025
Q1 		$33.1M Buy
+161,404
New +$31.4M 0.15% 30

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rakuten Investment Management's ABBV Position: Q1 2026 in Review

Rakuten Investment Management increased its AbbVie (ABBV) stake by 13% in Q1 2026, buying an estimated $6.62M and bringing the position to 262,298 shares worth $55.9M. The position accounts for 0.11% of the portfolio, ranked #33.

Rakuten Investment Management first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Rakuten Investment Management held 262,298 shares of AbbVie worth $55.9M as of Q1 2026.
  • Rakuten Investment Management bought 29,834 AbbVie shares in Q1 2026, an estimated $6.62M.
  • AbbVie made up 0.11% of Rakuten Investment Management's portfolio in Q1 2026, its #33 holding.
  • Rakuten Investment Management first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Rakuten Investment Management's 13F filing for Q1 2026, filed 12 May 2026.